(Q71970888)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7639806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7639806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

A randomized, double‐blind, placebo‐controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

4 July 2024

1 reference

1 reference

1 reference

P. A. van der Lubbe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7639806

4 July 2024

B. A. Dijkmans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7639806

4 July 2024

H. M. Markusse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7639806

4 July 2024

U. Nässander

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7639806

4 July 2024

F. C. Breedveld

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7639806

4 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7639806

4 July 2024

publication date

1 August 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7639806%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.1780380812

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7639806

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780380812

4 July 2024

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.1780380812

4 July 2024

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

4 July 2024

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7639806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7639806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7639806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

1097-1106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7639806%20AND%20SRC:MED&resulttype=core&format=json

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

4 July 2024

3

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

4 July 2024

4

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells

4 July 2024

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody

4 July 2024

6

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration

4 July 2024

7

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients.

4 July 2024

8

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone

4 July 2024

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis

4 July 2024

10

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis

4 July 2024

11

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Rheumatoid arthritis. Pathophysiology and implications for therapy

4 July 2024

13

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

4 July 2024

14

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Therapeutic criteria in rheumatoid arthritis

4 July 2024

15

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

4 July 2024

17

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Preliminary criteria for clinical remission in rheumatoid arthritis

4 July 2024

18

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies

4 July 2024

19

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody

4 July 2024

21

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action

4 July 2024

22

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts

4 July 2024

24

1 reference

https://api.crossref.org/works/10.1002/ART.1780380812

4 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7639806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference